{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:30:48Z","timestamp":1761989448672,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":833,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pathology Informatics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.4103\/jpi.jpi_66_19","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T03:11:14Z","timestamp":1585537874000},"page":"9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Individualized Bayesian Risk Assessment for Cervical Squamous Neoplasia"],"prefix":"10.1016","volume":"11","author":[{"given":"Lama F.","family":"Farchoukh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Onisko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Marshall","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4103\/jpi.jpi_66_19_bib1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"year":"2018","series-title":"SEER Cancer Statistics Review, 1975-2015","author":"Noone","key":"10.4103\/jpi.jpi_66_19_bib2"},{"key":"10.4103\/jpi.jpi_66_19_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2017.19872","article-title":"Screening for cervical cancer in primary care: A decision analysis for the us preventive services task force","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"key":"10.4103\/jpi.jpi_66_19_bib4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.5858\/134.5.744","article-title":"The Pittsburgh cervical cancer screening model: A risk assessment tool","volume":"134","author":"Austin","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.4103\/jpi.jpi_66_19_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/2153-3539.197191","article-title":"How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modeling","volume":"7","author":"Onisko","year":"2016","journal-title":"J Pathol Inform"},{"key":"10.4103\/jpi.jpi_66_19_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jasc.2015.05.001","article-title":"Increased cervical cancer risk associated with extended screening intervals after negative human papillomavirus test results: Bayesian risk estimates using the Pittsburgh cervical cancer screening model","volume":"5","author":"Austin","year":"2016","journal-title":"J Am Soc Cytopathol"},{"key":"10.4103\/jpi.jpi_66_19_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/dc.23993","article-title":"Application of Bayesian network modeling to pathology informatics","volume":"47","author":"Onisko","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"10.4103\/jpi.jpi_66_19_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0029-7844(97)00228-7","article-title":"Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening","volume":"90","author":"Lee","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.4103\/jpi.jpi_66_19_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jmv.2015","article-title":"Detection of highrisk HPV types by the hybrid capture 2 test","volume":"65","author":"Terry","year":"2001","journal-title":"J Med Virol"},{"key":"10.4103\/jpi.jpi_66_19_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2010.04.013","article-title":"Clinical validation of the Cervista HPV HR and 16\/18 genotyping tests for use in women with ASC-US cytology","volume":"118","author":"Einstein","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.4103\/jpi.jpi_66_19_bib11","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1128\/JCM.01013-15","article-title":"Head-to-head comparison of the rna-based aptima human papillomavirus (HPV) assay and the DNA-based hybrid capture 2 HPV test in a routine screening population of women aged 30 to 60 years in Germany","volume":"53","author":"Iftner","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.4103\/jpi.jpi_66_19_bib12","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system: Terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.4103\/jpi.jpi_66_19_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.39219.645475.55","article-title":"Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: Prospective study","volume":"335","author":"Davey","year":"2007","journal-title":"BMJ"},{"key":"10.4103\/jpi.jpi_66_19_bib14","first-page":"e111","article-title":"Committee on Practice Bulletins\u2014Gynecology. Practice bulletin no. 168: Cervical cancer screening and prevention","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.4103\/jpi.jpi_66_19_bib15","first-page":"147","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.4103\/jpi.jpi_66_19_bib16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"10.4103\/jpi.jpi_66_19_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/AOG.0b013e3181e3e719","article-title":"The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer","volume":"116","author":"Castle","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.4103\/jpi.jpi_66_19_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/LGT.0000000000000343","article-title":"Risks of CIN 2+, CIN 3+, and cancer by cytology and human papillomavirus status: The foundation of risk-based cervical screening guidelines","volume":"21","author":"Demarco","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"10.4103\/jpi.jpi_66_19_bib19","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/LGT.0b013e3182854282","article-title":"Five-year risks of CIN 3 + and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"10.4103\/jpi.jpi_66_19_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jnci\/djx225","article-title":"Relative performance of HPV and cytology components of cotesting in cervical screening","volume":"110","author":"Schiffman","year":"2018","journal-title":"J Natl Cancer Inst"},{"year":"2011","series-title":"Guidance for Industry and Food and Drug Administration Staff: Establishing the Performance Characteristics of In vitro Diagnostic Devices for the Detection or Detection and Differentiation of Human Papillomaviruses","author":"US Department of Health and Human Services, Food and Drug Administration","key":"10.4103\/jpi.jpi_66_19_bib21"},{"key":"10.4103\/jpi.jpi_66_19_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00006250-200305000-00043","article-title":"Screening interval and risk of invasive squamous cell cervical cancer","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.4103\/jpi.jpi_66_19_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.39363.471806.BE","article-title":"Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: Population based cohort study","volume":"335","author":"Strander","year":"2007","journal-title":"BMJ"},{"key":"10.4103\/jpi.jpi_66_19_bib24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/jwh.2011.3385","article-title":"Cervical cancer trends in the United States: A 35-year population-based analysis","volume":"21","author":"Adegoke","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"key":"10.4103\/jpi.jpi_66_19_bib25","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1158\/1055-9965.EPI-07-0278","article-title":"A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: Evidence of effectiveness and overtreatment","volume":"16","author":"Gunnell","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.4103\/jpi.jpi_66_19_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000326498","article-title":"Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening","volume":"47","author":"Kinney","year":"2003","journal-title":"Acta Cytol"},{"key":"10.4103\/jpi.jpi_66_19_bib27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U","article-title":"International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas","volume":"75","author":"Vizcaino","year":"1998","journal-title":"Int J Cancer"},{"key":"10.4103\/jpi.jpi_66_19_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.24410","article-title":"Screening and adenocarcinoma of the cervix","volume":"125","author":"Sasieni","year":"2009","journal-title":"Int J Cancer"},{"key":"10.4103\/jpi.jpi_66_19_bib29","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2468-2667(17)30007-5","article-title":"Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: Effectiveness and economic assessment for the National Cervical Screening Program","volume":"2","author":"Lew","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.4103\/jpi.jpi_66_19_bib30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/ijc.29053","article-title":"Sensitivity effect and overdiagnosis in screening for cancers with detectible preinvasive phase","volume":"136","author":"Hakama","year":"2014","journal-title":"Int J cancer"},{"key":"10.4103\/jpi.jpi_66_19_bib31","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/ijc.27850","article-title":"The HPV test has similar sensitivity but more overdiagnosis than the Pap test: A randomised health services study on cervical cancer screening in Finland","volume":"132","author":"Malila","year":"2013","journal-title":"Int J Cancer"}],"container-title":["Journal of Pathology Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2153353922002383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2153353922002383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:44:45Z","timestamp":1761871485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2153353922002383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2153353922002383"],"URL":"https:\/\/doi.org\/10.4103\/jpi.jpi_66_19","relation":{},"ISSN":["2153-3539"],"issn-type":[{"type":"print","value":"2153-3539"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individualized Bayesian Risk Assessment for Cervical Squamous Neoplasia","name":"articletitle","label":"Article Title"},{"value":"Journal of Pathology Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4103\/jpi.jpi_66_19","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 THE AUTHORS. Published by Elsevier Inc on behalf of the Association for Pathology Informatics","name":"copyright","label":"Copyright"}],"article-number":"9"}}